Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)